Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| beta-Lactamases | 10 | 2018 | 304 | 0.850 |
Why?
|
| Ceftazidime | 5 | 2017 | 68 | 0.580 |
Why?
|
| beta-Lactam Resistance | 5 | 2018 | 79 | 0.430 |
Why?
|
| Burkholderia | 3 | 2018 | 38 | 0.410 |
Why?
|
| Azabicyclo Compounds | 3 | 2017 | 68 | 0.390 |
Why?
|
| Burkholderia Infections | 2 | 2018 | 44 | 0.300 |
Why?
|
| beta-Lactams | 3 | 2015 | 159 | 0.240 |
Why?
|
| Anti-Bacterial Agents | 8 | 2018 | 7172 | 0.210 |
Why?
|
| Escherichia coli | 3 | 2015 | 4216 | 0.160 |
Why?
|
| Microbial Sensitivity Tests | 7 | 2018 | 1870 | 0.160 |
Why?
|
| Journal Impact Factor | 1 | 2019 | 155 | 0.150 |
Why?
|
| Burkholderia cepacia complex | 1 | 2017 | 25 | 0.150 |
Why?
|
| Leg Injuries | 1 | 2019 | 178 | 0.150 |
Why?
|
| Burkholderia pseudomallei | 1 | 2015 | 9 | 0.140 |
Why?
|
| Bacterial Proteins | 5 | 2018 | 3850 | 0.140 |
Why?
|
| Acinetobacter | 1 | 2012 | 39 | 0.110 |
Why?
|
| Carbapenems | 1 | 2013 | 117 | 0.110 |
Why?
|
| Enzyme Inhibitors | 2 | 2013 | 3794 | 0.100 |
Why?
|
| Penicillin-Binding Proteins | 1 | 2012 | 137 | 0.100 |
Why?
|
| Protons | 1 | 2017 | 1129 | 0.100 |
Why?
|
| Acinetobacter baumannii | 1 | 2012 | 107 | 0.100 |
Why?
|
| Cystic Fibrosis | 2 | 2017 | 1178 | 0.100 |
Why?
|
| Child Abuse | 1 | 2019 | 1030 | 0.090 |
Why?
|
| Gram-Negative Bacteria | 1 | 2010 | 271 | 0.080 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2019 | 1462 | 0.080 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 1458 | 0.080 |
Why?
|
| Fractures, Bone | 1 | 2019 | 1946 | 0.070 |
Why?
|
| Escherichia coli Proteins | 1 | 2013 | 1050 | 0.070 |
Why?
|
| Hydrogen Bonding | 2 | 2017 | 291 | 0.060 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2017 | 409 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2018 | 6535 | 0.050 |
Why?
|
| Catalytic Domain | 2 | 2015 | 697 | 0.050 |
Why?
|
| Drug Synergism | 2 | 2017 | 1794 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3917 | 0.050 |
Why?
|
| Kinetics | 3 | 2014 | 6476 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2018 | 4009 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 4803 | 0.040 |
Why?
|
| Phylogeny | 2 | 2017 | 2796 | 0.040 |
Why?
|
| Foot Injuries | 1 | 2019 | 148 | 0.040 |
Why?
|
| Moths | 1 | 2017 | 85 | 0.040 |
Why?
|
| Fracture Fixation | 1 | 2019 | 354 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2018 | 5445 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2019 | 1014 | 0.030 |
Why?
|
| Aztreonam | 1 | 2015 | 12 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 2017 | 6487 | 0.030 |
Why?
|
| Larva | 1 | 2017 | 515 | 0.030 |
Why?
|
| Opportunistic Infections | 1 | 2017 | 389 | 0.030 |
Why?
|
| Cephalosporins | 1 | 2015 | 203 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2018 | 13809 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2013 | 220 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2017 | 1245 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 1793 | 0.030 |
Why?
|
| Protein Binding | 2 | 2017 | 9377 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 2018 | 757 | 0.030 |
Why?
|
| Sulbactam | 1 | 2012 | 26 | 0.030 |
Why?
|
| Ampicillin | 1 | 2012 | 139 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2013 | 277 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2015 | 1723 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2013 | 683 | 0.030 |
Why?
|
| Publishing | 1 | 2019 | 833 | 0.020 |
Why?
|
| Boron Compounds | 1 | 2012 | 175 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2013 | 626 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 2011 | 0.020 |
Why?
|
| Solubility | 1 | 2012 | 1088 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 936 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2019 | 6356 | 0.020 |
Why?
|
| Penicillins | 1 | 2012 | 380 | 0.020 |
Why?
|
| Biological Assay | 1 | 2012 | 650 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2013 | 1263 | 0.020 |
Why?
|
| Species Specificity | 1 | 2013 | 2480 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2013 | 2839 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2012 | 1802 | 0.020 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2010 | 232 | 0.020 |
Why?
|
| Plasmids | 1 | 2013 | 2308 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2010 | 1677 | 0.020 |
Why?
|
| Drug Design | 1 | 2013 | 1075 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2010 | 1463 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 12243 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2019 | 7729 | 0.010 |
Why?
|
| Prevalence | 1 | 2019 | 15211 | 0.010 |
Why?
|
| Gene Expression | 1 | 2014 | 7793 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6170 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 18107 | 0.010 |
Why?
|
| Humans | 7 | 2019 | 743811 | 0.010 |
Why?
|
| Hospitalization | 1 | 2019 | 10259 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 40964 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 16361 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 14714 | 0.010 |
Why?
|
| Mutation | 1 | 2018 | 29777 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 72252 | 0.010 |
Why?
|
| United States | 1 | 2019 | 69859 | 0.010 |
Why?
|
| Child | 1 | 2019 | 77637 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 77410 | 0.010 |
Why?
|
| Animals | 1 | 2017 | 168660 | 0.000 |
Why?
|
| Male | 1 | 2019 | 349776 | 0.000 |
Why?
|
| Female | 1 | 2019 | 380020 | 0.000 |
Why?
|
Concepts
(96)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_